CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-α: relationship to CNS immune responses and depression

Cited by (629)

Items 201–300 of 629

1. Major depressive disorder as a neuro-immune disorder: Origin, mechanisms, and therapeutic opportunities
   Gislaine Z. Réus, Luana Meller Manosso, João Quevedo, Andre Ferrer Carvalho · 2023 · Neuroscience & Biobehavioral Reviews
2. Lipopolysaccharide-induced brain activation of the indoleamine 2,3-dioxygenase and depressive-like behavior are impaired in a mouse model of metabolic syndrome
   Anne‐Laure Dinel, Caroline André, Agnès Aubert, Guillaume Ferreira, Sophie Layé, Nathalie Castanon · 2013 · Psychoneuroendocrinology
3. Increased breakdown of kynurenine towards its neurotoxic branch in bipolar disorder
   A. Birner, M. Platzer, S. Bengesser, N. Dalkner, F. Fellendorf, R. Queissner, R. Pilz, P. Rauch, A. Maget, C. Hamm et al. · 2017 · PLoS ONE
4. Decreased quinolinic acid in the hippocampus of depressive patients: evidence for local anti-inflammatory and neuroprotective responses?
   M. Busse, Stefan Busse, A. Myint, T. Gos, H. Dobrowolny, Ulf J. Müller, B. Bogerts, H. Bernstein, J. Steiner · 2015 · European Archives of Psychiatry and Clinical Neuroscience
5. Upregulation of neuronal kynurenine 3-monooxygenase mediates depression-like behavior in a mouse model of neuropathic pain
   Geoffroy O. Laumet, Wenjun Zhou, Robert Dantzer, Jules D. Edralin, XiaoJiao Huo, David P. Budac, Jason C. O’Connor, Anna W. Lee, Cobi J. Heijnen, Annemieke Kavelaars · 2017 · Brain Behavior and Immunity
6. Tryptophan breakdown is increased in euthymic overweight individuals with bipolar disorder: a preliminary report
   Eva Z. Reininghaus, Roger S. McIntyre, Bernd Reininghaus, Simon Geisler, Susanne Bengesser, Nina Lackner, Karen Hecht, Armin Birner, Fabian Kattnig, Renate Unterweger et al. · 2013 · Bipolar Disorders
7. Inflammation-Associated Synaptic Alterations as Shared Threads in Depression and Multiple Sclerosis
   Antonio Bruno, Ettore Dolcetti, Francesca Romana Rizzo, Diego Fresegna, Alessandra Musella, Antonietta Gentile, Francesca De Vito, Silvia Caioli, Livia Guadalupi, Silvia Bullitta et al. · 2020 · Frontiers in Cellular Neuroscience
8. Beta-defensin 1, aryl hydrocarbon receptor and plasma kynurenine in major depressive disorder: metabolomics-informed genomics
   Duan Liu, Balmiki Ray, Drew R. Neavin, Jiabin Zhang, Arjun P. Athreya, Joanna M. Biernacka, William Victor Bobo, Daniel K. Hall‐Flavin, Michelle K. Skime, Hongjie Zhu et al. · 2018 · Translational Psychiatry
9. Suicide risk in hepatitis C and during interferon-alpha therapy: a review and clinical update
   Sanjeev Sockalingam, Paul S. Links, Susan E Abbey · 2010 · Journal of Viral Hepatitis
10. The Kynurenine Pathway in Traumatic Brain Injury: Implications for Psychiatric Outcomes
    Timothy Bradley Meier, Jonathan B. Savitz · 2021 · Biological Psychiatry
11. Glia in the cytokine-mediated onset of depression: fine tuning the immune response
    Wendy Karen Jo, Yuanyuan Zhang, Hinderk Meiners Emrich, Detlef E. Dietrich · 2015 · Frontiers in Cellular Neuroscience
12. Lipopolysaccharide-Induced Depressive-Like Behavior is Associated with α1-Adrenoceptor Dependent Downregulation of the Membrane GluR1 Subunit in the Mouse Medial Prefrontal Cortex and Ventral Tegmental Area
    Sekio, Miyu, Seki, Kenjiro · 2015 · International Journal of Neuropsychopharmacology
13. Sleep disturbance and kynurenine metabolism in depression
    Hyong Jin Cho, Jonathan B. Savitz, Robert Dantzer, T. Kent Teague, Wayne Curtis Drevets, Michael R. Irwin · 2017 · Journal of Psychosomatic Research
14. IDO and TDO as a potential therapeutic target in different types of depression
    Yanjie Qin, Nanxi Wang, Xinlin Zhang, Xuemei Han, Xuejia Zhai, Yongning Lu · 2018 · Metabolic Brain Disease
15. Acute Changes in Striatal Microstructure Predict the Development of Interferon-Alpha Induced Fatigue
    Dowell, Nicholas G., Cooper, Ella A., Tibble, Jeremy, Voon, Valerie, Critchley, Hugo D., Cercignani, Mara, Harrison, Neil A. · 2016 · Biological Psychiatry
16. Effects of Sleep Deprivation on the Tryptophan Metabolism
    Abid Bhat, Ananda Staats Pires, Vanessa X. Tan, Saravana Babu Chidambaram, Gilles J. Guillemin · 2020 · International Journal of Tryptophan Research
17. Prebiotic and probiotic supplementation and the tryptophan-kynurenine pathway: A systematic review and meta analysis
    Terry Purton, Lada Staskova, Melissa M. Lane, Samantha L. Dawson, Madeline L. West, Joseph Firth, Gerard A. Clarke, John F. Cryan, Michael Berk, Adrienne E O'Neil et al. · 2021 · Neuroscience & Biobehavioral Reviews
18. How Oxidative Stress Induces Depression?
    Na Ji, Mengzhu Lei, Yating Chen, Shaowen Tian, Chuanyu Li, Bo Zhang · 2023 · ASN NEURO
19. Minocycline and aspirin in the treatment of bipolar depression: a protocol for a proof-of-concept, randomised, double-blind, placebo-controlled, 2×2 clinical trial
    Jonathan B. Savitz, Sheldon Preskorn, T. Kent Teague, Douglas A. Drevets, William R. Yates, Wayne Drevets · 2012 · BMJ Open
20. Systemic inflammation is associated with depressive symptoms differentially by sex and race: a longitudinal study of urban adults
    May A. Beydoun, Hardeep K. Obhi, Jordan Weiss, Jose A. Canas, Hind A. Beydoun, Michele K. Evans, Alan B. Zonderman · 2019 · Molecular Psychiatry
21. Treatment-resistant depression: molecular mechanisms and management
    Mayanja M. Kajumba, Angelina Kakooza‐Mwesige, Noeline Nakasujja, Deborah Koltai Attix, Turhan Canli · 2024 · Molecular Biomedicine
22. Neuroinflammation and Depression
    M. Elizabeth Sublette, Teodor T. Postolache · 2012 · Psychosomatic Medicine
23. International Union of Basic and Clinical Pharmacology CIV: The Neurobiology of Treatment-resistant Depression: From Antidepressant Classifications to Novel Pharmacological Targets
    Filippo Caraci, Francesca Calabrese, Raffaella Molteni, Lucie Bartova, Markus Dold, Gian Marco Leggio, Chiara Fabbri, Julien Mendlewicz, Giorgio Racagni, Siegfried F. Kasper et al. · 2018 · Pharmacological Reviews
24. Second generation atypical antipsychotics olanzapine and aripiprazole reduce expression and secretion of inflammatory cytokines in human immune cells
    Britta Stapel, Irina Sieve, Christine Susanne Falk, Stefan Bleich, Denise Hilfiker‐Kleiner, Kai G. Kahl · 2018 · Journal of Psychiatric Research
25. Cerebrospinal fluid kynurenines in multiple sclerosis; relation to disease course and neurocognitive symptoms.
    S. Aeinehband, P. Brenner, S. Ståhl, M. Bhat, M. Fidock, M. Khademi, T. Olsson, G. Engberg, J. Jokinen, S. Erhardt et al. · 2016 · Brain, behavior, and immunity
26. Differences in immunomodulatory properties between venlafaxine and paroxetine in patients with major depressive disorder
    Chun‐Yen Chen, Yi‐Wei Yeh, Shin-Chang Kuo, Chih‐Sung Liang, Pei‐Shen Ho, Chang‐Chih Huang, Che-Hung Yen, Jia‐Fwu Shyu, Ru‐Band Lu, San‐Yuan Huang · 2017 · Psychoneuroendocrinology
27. The Relationships among Tryptophan, Kynurenine, Indoleamine 2,3-Dioxygenase, Depression, and Neuropsychological Performance
    Knut Asbjørn Hestad, Knut Engedal, Jon Elling Whist, Per G. Farup · 2017 · Frontiers in Psychology
28. Childhood Adversity and Current Stress are related to Pro- and Anti-inflammatory Cytokines in Major Depression
    Norbert Müller, Daniela Krause, Rike Barth, Aye-Mu Myint, Elif Weidinger, Waltraud Stettinger, Peter Zill, Hemmo A. Drexhage, Markus Schwarz · 2019 · Journal of Affective Disorders
29. Nutrition-based interventions for mood disorders
    Laís Bhering Martins, Jenneffer Rayane Braga Tibães, Marsal Sanches, Felice N. Jacka, Michael Berk, Antônio Lúcio Teixeira · 2021 · Expert Review of Neurotherapeutics
30. Neuron-related blood inflammatory markers as an objective evaluation tool for major depressive disorder: An exploratory pilot case-control study
    Nobuki Kuwano, Takahiro A. Kato, Masato Mitsuhashi, Mina Sato‐Kasai, Norihiro Shimokawa, Kohei Hayakawa, Masahiro Ohgidani, Noriaki Sagata, Hiroaki Kubo, Takeshi Sakurai et al. · 2018 · Journal of Affective Disorders
31. The role and mechanism of tryptophan – kynurenine metabolic pathway in depression
    Xiaoli Gong, Rui Chang, Ju Zou, Sijie Tan, Zeyi Huang · 2022 · Reviews in the Neurosciences
32. The inflammatory underpinning of depression: An historical perspective
    Raz Yirmiya · 2024 · Brain Behavior and Immunity
33. Quinolinic Acid and Nuclear Factor Erythroid 2-Related Factor 2 in Depression: Role in Neuroprogression
    Yashika Bansal, Raghunath Singh, Ishwar S. Parhar, Anurag Kuhad, Tomoko Soga · 2019 · Frontiers in Pharmacology
34. The immune-kynurenine pathway in social anxiety disorder
    Mary Butler, Caitríona M. Long-Smith, Gerard M. Moloney, Sabrina Mörkl, Siobhain M. O’Mahony, John F. Cryan, Gerard A. Clarke, Timothy G. Dinan · 2021 · Brain Behavior and Immunity
35. p21Ciprestrains hippocampal neurogenesis and protects neuronal progenitors from apoptosis during acute systemic inflammation
    Svetlana Zonis, Vladimir A. Ljubimov, Michael Y Mahgerefteh, Robert N. Pechnick, Kolja Wawrowsky, Vera Chesnokova · 2013 · Hippocampus
36. The impact of electroconvulsive therapy on the tryptophan–kynurenine metabolic pathway
    Sinan Gülöksüz, Baer M.G. Arts, Sharon Walter, Marjan Drukker, Laura Rodriguez, Aye-Mu Myint, Markus Schwarz, Rudolf Ponds, Jim van Os, Günter Kenis et al. · 2015 · Brain Behavior and Immunity
37. Microglial Cells as a Link between Cannabinoids and the Immune Hypothesis of Psychiatric Disorders
    Sabrina Francesca de Souza Lisboa, Felipe V. Gomes, Francisco Silveira Guimarães, Alline Cristina Campos · 2016 · Frontiers in Neurology
38. Pathogen–Host Defense in the Evolution of Depression: Insights into Epidemiology, Genetics, Bioregional Differences and Female Preponderance
    Charles L. Raison, Andrew H. Miller · 2016 · Neuropsychopharmacology
39. Neuroinflammation at the interface of depression and cardiovascular disease: Evidence from rodent models of social stress
    Julie E. Finnell, Susan K. Wood · 2016 · Neurobiology of Stress
40. Inflammation as a Pathophysiologic Pathway to Anhedonia: Mechanisms and Therapeutic Implications
    Mandakh Bekhbat, Michael Tilghman Treadway, Jennifer C. Felger · 2022 · Current topics in behavioral neurosciences
41. The possible role of the kynurenine pathway in anhedonia in adolescents
    Vilma Gabbay, Benjamin A. Ely, James S. Babb, Leonard Liebes · 2011 · Journal of Neural Transmission
42. Kynurenine Pathway in Autism Spectrum Disorders in Children
    Vesna Bryn, Robert M. Verkerk, Ola H. Skjeldal, Ola Didrik Saugstad, Heidi Ormstad · 2017 · Neuropsychobiology
43. Interferon-alpha-induced depression: Comparisons between early- and late-onset subgroups and with patients with major depressive disorder
    Kuan‐Pin Su, Hsueh‐Chou Lai, Cheng‐Yuan Peng, Wen‐Pang Su, Jane Pei‐Chen Chang, Carmine Maria Pariante · 2019 · Brain Behavior and Immunity
44. Interferon and anti-TNF therapies differentially modulate amygdala reactivity which predicts associated bidirectional changes in depressive symptoms
    Kevin A. Davies, Ella Cooper, Valerie Voon, Jeremy A. Tibble, Mara Cercignani, Neil Andrew Harrison · 2020 · Molecular Psychiatry
45. Stressor-induced NMDAR dysfunction as a unifying hypothesis for the aetiology, pathogenesis and comorbidity of clinical depression
    W.N. Marsden · 2011 · Medical Hypotheses
46. Brain-immune crosstalk in the treatment of major depressive disorder
    Igor Branchi, Silvia Poggini, Lucile Capuron, Francesco Benedetti, Sara Poletti, Ryad Tamouza, Hemmo A. Drexhage, Brenda W.J.H. Penninx, Carmine Maria Pariante · 2020 · European Neuropsychopharmacology
47. Serotonin and interleukin-6: The role of genetic polymorphisms in IFN-induced neuropsychiatric symptoms
    Marc Udina, J. Moreno-España, Ricard Navinés, Maria Dolors Giménez, Klaus Langohr, Mónica Gratacòs, Lucile Capuron, Rafael de la Torre, Ricard L. Sola, Rocío Martín‐Santos · 2013 · Psychoneuroendocrinology
48. Tryptophan pathway alterations in the postpartum period and in acute postpartum psychosis and depression
    Cato Veen, Aye-Mu Myint, Karin M. Burgerhout, Markus Schwarz, Gregor A. Schütze, Steven A. Kushner, Witte J.G. Hoogendijk, Hemmo A. Drexhage, Veerle Bergink · 2015 · Journal of Affective Disorders
49. Co-occurrence of Fatigue and Depression in People With Multiple Sclerosis: A Mini-Review
    Joanna Tarasiuk, Katarzyna Kapica-Topczewska, Agata Czarnowska, Monika Chorąży, Jan Kochanowicz, Alina Kułakowska · 2022 · Frontiers in Neurology
50. Multiple sclerosis, seizures, and antiepileptics: role of IL-18, IDO, and melatonin
    George Anderson, Moses Rodriguez · 2010 · European Journal of Neurology
51. Major Depressive Disorder and gut microbiota – Association not causation. A scoping review
    Igor Łoniewski, Agata Misera, Karolina Skonieczna‐Żydecka, Mariusz Kaczmarczyk, Karolina Kaźmierczak-Siedlecka, Błażej Misiak, Wojciech M. Marlicz, Jerzy Samochowiec · 2020 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
52. Tetrahydrobiopterin Biosynthesis as a Potential Target of the Kynurenine Pathway Metabolite Xanthurenic Acid
    Hirohito Haruki, Ruud Hovius, Miriam Grønlund Pedersen, Kai Johnsson · 2015 · Journal of Biological Chemistry
53. Chronic Mild Stress Alters Kynurenine Pathways Changing the Glutamate Neurotransmission in Frontal Cortex of Rats
    David Martín‐Hernández, Hiram Tendilla‐Beltrán, José L. M. Madrigal, Borja García‐Bueno, Juan Carlos Leza, Javier R. Caso · 2018 · Molecular Neurobiology
54. Interferon-alpha treatment induces depression-like behaviour accompanied by elevated hippocampal quinolinic acid levels in rats
    Christina Weide Fischer, Amanda Eskelund, David P. Budac, Sandra Tillmann, Nico Liebenberg, Betina Elfving, Gregers Wegener · 2015 · Behavioural Brain Research
55. Understanding the role of P2X7 in affective disorders—are glial cells the major players?
    Leanne Stokes, Sarah J. Spencer, Trisha A. Jenkins · 2015 · Frontiers in Cellular Neuroscience
56. Biological mechanisms of depression following treatment with interferon for chronic hepatitis C: A critical systematic review
    Myrela O. Machado, Giovanni Oriolo, Beatrice Bortolato, Cristiano André Köhler, Michael H. J. Maes, Marco Solmi, Iría Grande, Rocío Martín‐Santos, Eduard Vieta, Andre Ferrer Carvalho · 2016 · Journal of Affective Disorders
57. Kynurenine metabolism and inflammation-induced depressed mood: a human experimental study
    Kruse, Jennifer L., Cho, Joshua Hyong-Jin, Olmstead, Richard, Hwang, Lin, Faull, Kym, Eisenberger, Naomi I., Irwin, Michael R. · 2019 · Psychoneuroendocrinology
58. Neuronal Mitochondrial Dysfunction and Bioenergetic Failure in Inflammation-Associated Depression
    Angela Maria Casaril, Robert Dantzer, Carlos Bas Orth · 2021 · Frontiers in Neuroscience
59. The Footprint of Kynurenine Pathway in Cardiovascular Diseases
    Moein Ala, Seyed Parsa Eftekhar · 2022 · International Journal of Tryptophan Research
60. Glial and tissue-specific regulation of Kynurenine Pathway dioxygenases by acute stress of mice
    Carlos R. Dostal, Megan Carson Sulzer, K. Kelley, G. Freund, R. H. McCusker · 2017 · Neurobiology of Stress
61. Oncology Therapeutics Targeting the Metabolism of Amino Acids
    Nefertiti Muhammad, Hyun Min Lee, Jiyeon Kim · 2020 · Cells
62. Cross-sectional relationship between kynurenine pathway metabolites and cognitive function in major depressive disorder
    Yanling Zhou, Wei Zheng, Weijian Liu, Chengyu Wang, Yanni Zhan, Hanqiu Li, Lijian Chen, Yuping Ning · 2018 · Psychoneuroendocrinology
63. Neurobehavioral Effects of Interferon-α in Patients with Hepatitis-C: Symptom Dimensions and Responsiveness to Paroxetine
    McNutt, Marcia D, Liu, Shuling, Manatunga, Amita, Royster, Erica B, Raison, Charles L, Woolwine, Bobbi J, Demetrashvili, Marina F, Miller, Andrew H, Musselman, Dominique L · 2012 · Neuropsychopharmacology
64. COVID-19, Oxidative Stress, and Neuroinflammation in the Depression Route
    Maiqueli Eduarda Dama Mingoti, Amanda Gollo Bertollo, Júlia Leão Batista Simões, Gabriel Rossi Francisco, Margarete Dulce Bagatini, Zuleide Maria Ignácio · 2022 · Journal of Molecular Neuroscience
65. A Biopsychosocial Model of Interferon-Alpha-Induced Depression in Patients with Chronic Hepatitis C Infection
    Andreas Baranyi, Andreas Meinitzer, Alexandra Stepan, Csilla Putz‐Bankuti, Robert J. Breitenecker, Rudolf E Stauber, Hans‐Peter Kapfhammer, Hans‐Bernd Rothenhäusler · 2013 · Psychotherapy and Psychosomatics
66. Toward an Anti-Inflammatory Strategy for Depression
    Shawn P. Hayley · 2011 · Frontiers in Behavioral Neuroscience
67. Regulation of proinflammatory monocyte activation by the kynurenine–AhR axis underlies immunometabolic control of depressive behavior in mice
    Xiaojie Zang, Xiao Zheng, Yuanlong Hou, Miaomiao Hu, Hong Wang, Xiaoqiang Bao, Fang Zhou, Guangji Wang, Haiping Hao · 2017 · The FASEB Journal
68. Molecular signatures of peripheral blood mononuclear cells during chronic interferon-α treatment: relationship with depression and fatigue
    Jennifer C. Felger, Steve W. Cole, Thaddeus W. W. Pace, Fang Hu, Bobbi J. Woolwine, Gregory Doho, Charles L. Raison, Andrew H. Miller · 2011 · Psychological Medicine
69. Cerebrospinal fluid metabolomics: detection of neuroinflammation in human central nervous system disease
    Jingya Yan, U. Kuzhiumparambil, S. Bandodkar, R. Dale, Shan-Lin Fu · 2021 · Clinical & Translational Immunology
70. Simvastatin therapy in adolescent mice attenuates HFD-induced depression-like behavior by reducing hippocampal neuroinflammation
    Wu, Huali, Lv, Wenting, Pan, Qi, Kalavagunta, Praveen Kumar, Liu, Qiongzhen, Qin, Guohong, Cai, Minxuan, Zhou, Liangliang, Wang, Tao, Xia, Zhenjiang et al. · 2019 · Journal of Affective Disorders
71. Quinolinic acid is associated with cognitive deficits in schizophrenia but not major depressive disorder
    Flurin Cathomas, Karoline Guetter, Erich Seifritz, Federica Klaus, Stefan Kaiser · 2021 · Scientific Reports
72. Selective association of cytokine levels and kynurenine/tryptophan ratio with alterations in white matter microstructure in bipolar but not in unipolar depression
    Stefano Comai, Elisa Maria Teresa Melloni, Cristina Lorenzi, Irene Bollettini, Benedetta Vai, Raffaella Zanardi, Cristina Colombo, Flavia Valtorta, Francesco Benedetti, Sara Poletti · 2021 · European Neuropsychopharmacology
73. An integrated cytokine and kynurenine network as the basis of neuroimmune communication
    Trevor W. Stone, Felix I. L. Clanchy, Yishu Huang, Nien‐Yi Chiang, Lynda Gail Darlington, Richard O. Williams · 2022 · Frontiers in Neuroscience
74. Behavioral Deficits Are Accompanied by Immunological and Neurochemical Changes in a Mouse Model for Neuropsychiatric Lupus (NP-SLE)
    Yan Li, Amanda Eskelund, Hua Zhou, David P. Budac, Connie Sánchez, Maria E. Gulinello · 2015 · International Journal of Molecular Sciences
75. Peripheral indoleamine 2,3-dioxygenase 1 is required for comorbid depression-like behavior but does not contribute to neuropathic pain in mice
    Wenjun Zhou, Robert Dantzer, David P. Budac, Adam K. Walker, Qi‐Liang Mao‐Ying, Anna W. Lee, Cobi J. Heijnen, Annemieke Kavelaars · 2015 · Brain Behavior and Immunity
76. Tryptophan breakdown and cognition in bipolar disorder
    Martina Platzer, Nina Dalkner, Frederike T. Fellendorf, Armin Birner, Susanne Bengesser, Robert Queissner, Nora Kainzbauer, René Pilz, Simone Herzog-Eberhard, Carlo Hamm et al. · 2017 · Psychoneuroendocrinology
77. Depressive symptoms as a side effect of Interferon-α therapy induced by induction of indoleamine 2,3-dioxygenase 1
    Murakami, Yuki, Ishibashi, Takaaki, Tomita, Eiichi, Imamura, Yukio, Tashiro, Tomoyuki, Watcharanurak, Kanitta, Nishikawa, Makiya, Takahashi, Yuki, Takakura, Yoshinobu, Mitani, Satoko et al. · 2016 · Scientific Reports
78. Depressive Symptoms in Crohn's Disease: Relationship with Immune Activation and Tryptophan Availability
    Sinan Gülöksüz, Marieke Wichers, Günter Kenis, Maurice G. Rüssel, Annick Wauters, Robert M. Verkerk, Baer M.G. Arts, Jim van Os · 2013 · PLoS ONE
79. Drugs with antidepressant properties affect tryptophan metabolites differently in rodent models with depression‐like behavior
    A. Eskelund, Yan Li, D. Budac, H. Müller, M. Gulinello, C. Sánchez, G. Wegener · 2017 · Journal of Neurochemistry
80. Prophylactic (R,S)-ketamine selectively protects against inflammatory stressors
    Mastrodonato, Alessia, Cohensedgh, Omid, LaGamma, Christina T., McGowan, Josephine C., Hunsberger, Holly C., Denny, Christine A. · 2020 · Behavioural Brain Research
81. Ongoing episode of major depressive disorder is not associated with elevated plasma levels of kynurenine pathway markers
    Johan Dahl, Ole A. Andreassen, Robert M. Verkerk, Ulrik Fredrik Malt, Leiv Sandvik, Lena Brundin, Heidi Ormstad · 2015 · Psychoneuroendocrinology
82. Why Severe COVID-19 Patients Are at Greater Risk of Developing Depression: A Molecular Perspective
    Ana Paula Bouças, Jakeline Rheinheimer, Jim Lagopoulos · 2020 · The Neuroscientist
83. Tryptophan metabolite concentrations in depressed patients before and after electroconvulsive therapy
    Karen M. Ryan, Kelly Ann Allers, Declan M. McLoughlin, Andrew Harkin · 2019 · Brain Behavior and Immunity
84. Advances in the mechanisms of polysaccharides in alleviating depression and its complications
    Yuxi Guo, Xuefeng Chen, Pin Gong, Zixuan Li, Yanping Wu, Jie Zhang, Jiating Wang, Wenbo Yao, Wenjuan Yang, Fuxin Chen · 2022 · Phytomedicine
85. Tryptophan and Its Metabolite Serotonin Impact Metabolic and Mental Disorders via the Brain–Gut–Microbiome Axis: A Focus on Sex Differences
    M. Xu, Ethan Y. Zhou, Haifei Shi · 2025 · Cells
86. Inflammatory Pathways in Psychiatric Disorders: the Case of Schizophrenia and Depression
    Tami Feng, Ashutosh Tripathi, Anilkumar Pillai · 2020 · Current Behavioral Neuroscience Reports
87. Bupropion pre-treatment of endotoxin-induced depressive symptoms
    Nicole DellaGioia, Lesley Devine, Brian P. Pittman, Jonas O. Hannestad · 2012 · Brain Behavior and Immunity
88. Fluoxetine prevents the development of depressive-like behavior in a mouse model of cancer related fatigue
    Diana M. Norden, Raymond D. Devine, Sabahattin Bicer, Runfeng Jing, Peter J. Reiser, Loren E. Wold, Jonathan P. Godbout, Donna O. McCarthy · 2014 · Physiology & Behavior
89. The role of the kynurenine pathway and quinolinic acid in adolescent major depressive disorder
    M. Öztürk, Şermin Yalın Sapmaz, H. Kandemir, F. Taneli, Ö. Aydemir · 2020 · International journal of clinical practice
90. Quinolinic acid, a kynurenine/tryptophan pathway metabolite, associates with impaired cognitive test performance in systemic lupus erythematosus
    Erik Anderson, Joanna Stein Fishbein, Joseph Hong, Julien Roeser, Richard Alan Furie, Cynthia B. Aranow, Bruce T. Volpe, Betty Diamond, Meggan C. Mackay · 2021 · Lupus Science & Medicine
91. The impact of adult neurogenesis on affective functions: of mice and men
    Mariana Alonso, Anne-Cécile Petit, P. Lledo · 2024 · Molecular Psychiatry
92. Interferon-alpha-induced inflammation is associated with reduced glucocorticoid negative feedback sensitivity and depression in patients with hepatitis C virus
    Jennifer C. Felger, Ebrahim Haroon, Bobbi J. Woolwine, Charles L. Raison, Andrew H. Miller · 2015 · Physiology & Behavior
93. The Sex-specific Effects of LPS on Depressive-like Behavior and Oxidative Stress in the Hippocampus of the Mouse
    Caitlin E. Millett, Brett Eugene Phillips, Erika F.H. Saunders · 2018 · Neuroscience
94. The Role of Molecular and Inflammatory Indicators in the Assessment of Cognitive Dysfunction in a Mouse Model of Diabetes
    Iwona Piątkowska‐Chmiel, Mariola Herbet, Monika Gawrońska‐Grzywacz, Marta Ostrowska-Leśko, Jarosław Dudka · 2021 · International Journal of Molecular Sciences
95. Behavioral disturbances in adult mice following neonatal virus infection or kynurenine treatment – role of brain kynurenic acid
    Xi-Cong Liu, M. Holtze, S. Powell, N. Terrando, M. Larsson, Anna‐Karin Persson, S. Olsson, F. Orhan, Magdalena E. Kegel, L. Asp et al. · 2013 · Brain, behavior, and immunity
96. Relationships between inflammatory markers and suicide risk status in major depression
    Licínia Ganança, Hanga Galfalvy, Sebastian Cisneros-Trujillo, Zahra Basseda, Thomas B. Cooper, Xinguo Ren, Maria Luísa Figueira, María A. Oquendo, J. John Mann, M. Elizabeth Sublette · 2020 · Journal of Psychiatric Research
97. Modulation of neuroimmune cytokine networks by antidepressants: implications in mood regulation
    Roseane Galdioli Nava, Anny Silva Adri, Igor Salerno Filgueiras, Adriel Leal Nóbile, Pedro Marçal Barcelos, Yohan Lucas Gonçalves Corrêa, Sérgio Ferreira de Oliveira, Gustavo Cabral‐Miranda, Haroldo Dutra Dias, Lena F. Schimke et al. · 2025 · Translational Psychiatry
98. Quinolinic acid/tryptophan ratios predict neurological disease in SIV-infected macaques and remain elevated in the brain under cART
    Julia L. Drewes, Kelly A. Meulendyke, Zhaohao Liao, Kenneth Whitaker Witwer, Lúcio Gama, Ceereena Ubaida‐Mohien, Ming Li, Francesca M. Notarangelo, Patrick M. Tarwater, Robert M. Schwarcz et al. · 2015 · Journal of NeuroVirology
99. Tryptophan metabolic profile in term and preterm breast milk: implications for health
    Louise O'Rourke, G. Clarke, Aoife M. Nolan, C. Watkins, T. Dinan, C. Stanton, R. Ross, C. Ryan · 2018 · Journal of Nutritional Science
100. Linking the cytokine and neurocircuitry hypotheses of depression: A translational framework for discovery and development of novel anti-depressants
     Timothy M. Piser · 2010 · Brain Behavior and Immunity